Literature DB >> 24080284

Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.

Xiao Dong Gai1, Yang Song, Chun Li, Yan Ming Lei, Baoxue Yang.   

Abstract

FOXP3(+) regulatory T cells (Tregs) play an important role in the maintenance of tumor immunity tolerance. Compared with conventional myeloid dentritic cells (mDCs), plasmacytoid dendritic cells (pDCs) exhibit poor immunostimulatory ability, and their interaction with T cells often promotes the development of Tregs. The aim of this study was to determine FOXP3(+) Tregs and CD123(+)pDCs infiltration in colorectal cancer and tumor draining lymph node (TDLN), and to evaluate the clinical significance and relationship between pDCs infiltration and Tregs development in the CRC tolerogenic milieu. An immunohistochemical assay was conducted to assess FOXP3(+)Tregs and CD123(+)pDCs infiltration in tumor tissue and in metastatic-free TDLN (mfTDLN) and metastatic TDLN (mTDLN). The results showed that FOXP3(+) Tregs infiltration was more frequent in tumor tissue than in adjacent normal mucosa (P<0.001). FOXP3(+)Tregs infiltration was associated with advanced TNM stage and lymph node metastasis (P<0.01 and P<0.01 for TNM stage and lymph node metastasis, respectively). Different from FOXP3(+)Tregs, CD123(+)pDCs frequencies were lower in most CRC tumor tissues, whereas the positive rate of CD123 expression in CRC was significantly higher than in adjacent normal mucosa tissue (P<0.01). Compared to mfTDLN, mTDLN was significantly enriched in FOXP3(+) Tregs (P<0.01) and increased in pDC/mDC ratio (P<0.01). The statistical analysis demonstrated a significant correlation in both Tregs and pDC/mDC ratio in mTDLN. These results suggest that there are more FOXP3(+) Tregs with a stronger prognostic significance which might promote tumor tolerance, and that CD123(+)pDCs might contribute to Tregs development in the CRC tolerogenic milieu.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Immunohistochemistry; Plasmacytoid dentritic cells; Regulatory T cells; Tumor draining lymph nodes

Mesh:

Substances:

Year:  2013        PMID: 24080284     DOI: 10.1016/j.prp.2013.08.011

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

Review 1.  Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer.

Authors:  Ling Ni
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

2.  Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.

Authors:  Min Hu; Kai Li; Ninu Maskey; Zhigao Xu; Chunwei Peng; Bicheng Wang; Yan Li; Guifang Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

3.  A key role of GARP in the immune suppressive tumor microenvironment.

Authors:  Susanne A Hahn; Annemarie Neuhoff; Jenny Landsberg; Jonathan Schupp; Daniela Eberts; Petra Leukel; Matthias Bros; Martin Weilbaecher; Detlef Schuppan; Stephan Grabbe; Thomas Tueting; Volker Lennerz; Clemens Sommer; Helmut Jonuleit; Andrea Tuettenberg
Journal:  Oncotarget       Date:  2016-07-12

Review 4.  Disease-Associated Plasmacytoid Dendritic Cells.

Authors:  Shuang Li; Jing Wu; Shan Zhu; Yong-Jun Liu; Jingtao Chen
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

Review 5.  The Role of Plasmacytoid Dendritic Cells in Gut Health.

Authors:  Hye-Yeon Won; Ju-Young Lee; Dahye Ryu; Hyung-Taek Kim; Sun-Young Chang
Journal:  Immune Netw       Date:  2019-01-16       Impact factor: 6.303

6.  Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer.

Authors:  Felix Wagner; Ulrike Hölig; Friederike Wilczkowski; Ioana Plesca; Ulrich Sommer; Rebekka Wehner; Maximilian Kießler; Armin Jarosch; Katharina Flecke; Maia Arsova; Antje Tunger; Andreas Bogner; Christoph Reißfelder; Jürgen Weitz; Knut Schäkel; Esther G C Troost; Mechthild Krause; Gunnar Folprecht; Martin Bornhäuser; Michael P Bachmann; Daniela Aust; Gustavo Baretton; Marc Schmitz
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 7.  Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma.

Authors:  Matilde Monti; Francesca Consoli; Raffaella Vescovi; Mattia Bugatti; William Vermi
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600

8.  Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort.

Authors:  Yu-Jie Huang; Zhi-Fei Cao; Jie Wang; Jian Yang; Yi-Jun Wei; Yu-Chen Tang; Yin-Xiang Cheng; Jian Zhou; Zi-Xiang Zhang
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

Review 9.  Functions of Dendritic Cells and Its Association with Intestinal Diseases.

Authors:  Ze-Jun Yang; Bo-Ya Wang; Tian-Tian Wang; Fei-Fei Wang; Yue-Xin Guo; Rong-Xuan Hua; Hong-Wei Shang; Xin Lu; Jing-Dong Xu
Journal:  Cells       Date:  2021-03-06       Impact factor: 6.600

Review 10.  The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.

Authors:  Beatriz Subtil; Alessandra Cambi; Daniele V F Tauriello; I Jolanda M de Vries
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.